SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Milo Biotechnology Announces DSG, Inc. Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy